For example, analysis of liver biopsies from patients in the FLIGHT-FXR study showed that a reduction or an increase in qFibrosis parameters was demonstrable in cases where there is no change in the ordinal pathologist-assigned fibrosis score after treatment with tropifexor.27 This evidence concerns the gene NR1H4 and fibrosis.